Skip to main content
. 2019 Sep 17;14(10):2295–2304. doi: 10.1021/acschembio.9b00640

Figure 4.

Figure 4

Structure–activity relationships of lead inhibitors for ABHD. (A) Dose-dependent effect of 183 and 184 on ABHD2 labeling by MB064 (2 μM) on gel. (B) Dose–response curve of inhibitor 183 (pIC50 = 5.50 ± 0.06) and 184 (pIC50 = 4.60 ± 0.10).